Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real‐world analysis from 20 US centers
HemaSphere | March 31, 2026 | Volume: 10 | Issue: 4 | Pages: No page available
10.1002/hem3.70346
| PMID 42038745